Quantcast
 
New book by Larry Connors - Click here to read more


GSK

BRIEF-GSK gets positive phase 2b data on asthma drug - 12/02 - 08:36 AM ET

Business travel to India on hold - 12/01 - 11:07 AM ET

Philadelphians scramble to see Obama inauguration - 12/01 - 03:37 AM ET

Obama may tap Duke doctor: Califf mentioned as FDA candidate - 11/28 - 04:45 AM ET

BRIEF: More bad news for Avandia - 11/27 - 04:47 AM ET

BRIEF-Glaxo says not involved in latest EU raids - 11/25 - 01:44 PM ET

Dr Reddy's introduces generic Imitrex tablets in US - 11/25 - 11:42 AM ET

Study: Avandia riskier than Actos for older diabetics - 11/25 - 03:47 AM ET

UPDATE 1-Safety risks higher with Avandia than Actos -study - 11/24 - 10:16 PM ET

Safety risks higher with Avandia than Actos -study - 11/24 - 04:02 PM ET

GSK and Neptunus to form JV for co-development of flu vaccines - 11/24 - 07:08 AM ET

The News & Observer, Raleigh, N.C., Tim Stevens column: Enloe senior's scoring grabs attention - 11/23 - 05:26 AM ET

GSK wins FDA approval for platelet drug - 11/21 - 09:37 AM ET

AstraZeneca to divest Swedish OTC portfolio to GlaxoSmithKline - 11/21 - 09:35 AM ET

GlaxoSmithKline Rises In Pre-Market On FDA Approval Of Oral Medication, JV Deal With Neptunus - 11/21 - 08:22 AM ET

UPDATE 1-Glaxo forms Chinese flu vaccine joint venture - 11/21 - 05:48 AM ET

BRIEF-GlaxoSmithKline forms Chinese flu vaccine JV - 11/21 - 05:08 AM ET

UPDATE 1-Glaxo wins U.S. approval for platelet drug - 11/20 - 07:14 PM ET

Glaxo wins U.S. approval for platelet drug - 11/20 - 06:55 PM ET

FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder - 11/20 - 05:43 PM ET

Page 1 of 15     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index

 

Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.